ABT
Price
$129.39
Change
-$0.45 (-0.35%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
194.5B
84 days until earnings call
BAX
Price
$30.43
Change
+$0.83 (+2.80%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
21.77B
7 days until earnings call
Ad is loading...

ABT vs BAX

Header iconABT vs BAX Comparison
Open Charts ABT vs BAXBanner chart's image
Abbott Laboratories
Price$129.39
Change-$0.45 (-0.35%)
Volume$74.52K
Capitalization194.5B
Baxter International
Price$30.43
Change+$0.83 (+2.80%)
Volume$39.99K
Capitalization21.77B
ABT vs BAX Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. BAX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and BAX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ABT: $129.84 vs. BAX: $29.60)
Brand notoriety: ABT: Notable vs. BAX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 117% vs. BAX: 86%
Market capitalization -- ABT: $194.5B vs. BAX: $21.77B
ABT [@Medical Specialties] is valued at $194.5B. BAX’s [@Medical Specialties] market capitalization is $21.77B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 4 FA rating(s) are green whileBAX’s FA Score has 2 green FA rating(s).

  • ABT’s FA Score: 4 green, 1 red.
  • BAX’s FA Score: 2 green, 3 red.
According to our system of comparison, ABT is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 3 TA indicator(s) are bullish while BAX’s TA Score has 6 bullish TA indicator(s).

  • ABT’s TA Score: 3 bullish, 6 bearish.
  • BAX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BAX is a better buy in the short-term than ABT.

Price Growth

ABT (@Medical Specialties) experienced а +0.11% price change this week, while BAX (@Medical Specialties) price change was +6.40% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

ABT is expected to report earnings on Jul 17, 2025.

BAX is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than BAX($21.8B). BAX has higher P/E ratio than ABT: BAX (85.61) vs ABT (34.38). ABT YTD gains are higher at: 15.928 vs. BAX (2.003). ABT has higher annual earnings (EBITDA): 10.5B vs. BAX (1.67B). ABT has more cash in the bank: 7.28B vs. BAX (3.19B). BAX has less debt than ABT: BAX (14.4B) vs ABT (15.6B). ABT has higher revenues than BAX: ABT (40.1B) vs BAX (14.8B).
ABTBAXABT / BAX
Capitalization194B21.8B890%
EBITDA10.5B1.67B628%
Gain YTD15.9282.003795%
P/E Ratio34.3885.6140%
Revenue40.1B14.8B271%
Total Cash7.28B3.19B228%
Total Debt15.6B14.4B108%
FUNDAMENTALS RATINGS
ABT vs BAX: Fundamental Ratings
ABT
BAX
OUTLOOK RATING
1..100
2273
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
26100
SMR RATING
1..100
3291
PRICE GROWTH RATING
1..100
3163
P/E GROWTH RATING
1..100
9311
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (8) in the Medical Specialties industry is in the same range as ABT (11). This means that BAX’s stock grew similarly to ABT’s over the last 12 months.

ABT's Profit vs Risk Rating (26) in the Medical Specialties industry is significantly better than the same rating for BAX (100). This means that ABT’s stock grew significantly faster than BAX’s over the last 12 months.

ABT's SMR Rating (32) in the Medical Specialties industry is somewhat better than the same rating for BAX (91). This means that ABT’s stock grew somewhat faster than BAX’s over the last 12 months.

ABT's Price Growth Rating (31) in the Medical Specialties industry is in the same range as BAX (63). This means that ABT’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (11) in the Medical Specialties industry is significantly better than the same rating for ABT (93). This means that BAX’s stock grew significantly faster than ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTBAX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 8 days ago
59%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 21 days ago
50%
Bearish Trend 14 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UAMY3.440.18
+5.52%
United States Antimony Corp
TPG44.501.22
+2.82%
TPG
CLAR3.410.06
+1.79%
Clarus Corp
NVGS12.280.20
+1.66%
NAVIGATOR HOLDINGS Ltd
LNG228.09-1.71
-0.74%
Cheniere Energy

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-1.43%
MDT - ABT
50%
Loosely correlated
+0.46%
SYK - ABT
49%
Loosely correlated
+2.58%
BDX - ABT
44%
Loosely correlated
+1.22%
HOLX - ABT
43%
Loosely correlated
-0.07%
BAX - ABT
41%
Loosely correlated
+3.42%
More

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with RVTY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+3.42%
RVTY - BAX
48%
Loosely correlated
+1.46%
SYK - BAX
47%
Loosely correlated
+2.58%
BRKR - BAX
44%
Loosely correlated
+2.52%
IQV - BAX
44%
Loosely correlated
+2.40%
A - BAX
43%
Loosely correlated
+2.13%
More